ClinicalTrials.gg
CompletedNCT03454958TRANSPARENTSUpdated Nov 13, 2020

Body Weight, Body Composition and Energy Balance Related Behavior During the Transition to Parenthood

An observational study in Body Weight, Health Behavior and Pregnancy, sponsored by Vrije Universiteit Brussel. Completed at 4 sites in Belgium. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-13.

Primary conditionHealth BehaviorRegistry: Body WeightReclassifiedWhy we changed it
Registry
Body Weight — the first condition term the registry derived for this study.
ClinicalTrials.gg
Health Behavior
Why
  1. Body Weight is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Health Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Vrije Universiteit Brussel · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
304
Ages
18 Years and older
Sex
All
01

Study summary

Understanding critical periods during which people are at risk to gain weight or display unhealthy changes in energy balance related behaviour, i.e. eating, physical activity and sedentary behaviour, can facilitate the development of weight gain prevention programs. Although the transition to parenthood is associated with pregnancy-related weight gain and retention in women, evidence on the effect of having a first child on men's body weight is lacking. It is also unclear whether pregnancy-related weight gain and retention cohere with unfavourable changes in body composition and energy balance related behaviour in both women and men transitioning to parenthood. Using a mixed-methods design, the investigators aim to provide insight into this critical life phase. An observational follow-up study will be used to investigate changes in body weight, body composition and energy balance related behaviour among couples from pre-conception to one year postpartum, and to identify those most at risk for excessive weight gain.

Read the detailed description

The first objective of this research is to investigate both maternal and paternal changes in body weight, body composition and energy balance related behaviour during and after pregnancy in Flemish couples.

The second objective is to investigate socio-demographic and behavioural predictors of changes in both maternal and paternal body weight and body composition, in order to identify those most at risk for postpartum weight gain and retention.

Couples transitioning into parenthood (age ≥ 18 years, any BMI and socio-economic status) will be recruited during the first trimester of pregnancy by gynaecologists from the partner obstetrics units at five Flemish hospitals. All couples expecting their first child will be asked to participate in the study. Participants below 18 years of age, not speaking the Dutch language or suffering from a pathological condition that may influence energy balance related behaviour (e.g. diabetes, preeclampsia etc.) will be excluded.

Using a longitudinal design, participating couples (women and men) will be measured four times over the course of approximately one year and nine months. Baseline measurements (T0) will take place during the first trimester of pregnancy (at 12 weeks of pregnancy), with follow-up measurements at respectively six weeks (T1), and six (T2) and twelve months (T3) postpartum.

At baseline (T0), both retrospective and prospective measurements will be conducted in both pregnant women and men expecting their first child. Retrospectively, a self-report questionnaire will be used to assess body weight, height and energy balance related behaviour, incl. eating (Food Frequency Questionnaire (FFQ) which will be adapted for pregnant women), physical activity (International Physical Activity Questionnaire (IPAQ - Dutch version) and sedentary behaviour. The self-report questionnaire will also include questions about sleeping habits, smoking, and socio-demographics. Prospectively, body weight (SECA digital weighing scale), height (SECA stadiometer), body composition (TANITA Bioelectrical Impedance Analyzer \& skin fold thickness measurements at the biceps, triceps, subscapular and suprailiac sites) and waist circumference (Cescorf measuring tape) will be objectively measured. Women's gestational weight will be monitored by the gynaecologists as all pregnant women are being weighed during consultation. The same self-report questionnaire (see supra) will be used prospectively, including extra questions about breastfeeding and parental leave. In addition, dietary intake will be assessed by a 3-day food diary, whereas tri-axial accelerometers (Actigraph) will be used to measure energy expenditure (by rate of physical activity and sedentary behaviour) objectively over a one-week period. At followup moments (T1-3), the same aforementioned prospective measurements will be carried out.

02

Conditions studied

  • Body Weight
  • Health Behavior
  • Pregnancy
  • First Pregnancy

Browse trials for

03

In context

Health Behavior Reclassified

967 studies on the registry are indexed under Health Behavior; 165 are open to participants now.

This study's enrollment of 304 is above the median of 219 across 131 observational studies indexed under Health Behavior.

Browse Health Behavior studies →

Lead sponsor

Vrije Universiteit Brussel is the lead sponsor of 158 studies on the registry; 43 are open to participants now.

Compared within Health Behavior, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Body Weight. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Couples expecting their first child

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Couples expecting their first child (nulliparous women and men)
  • Participants aged ≥18 years
  • Participants with any
  • Participants from any socio-economic status (SES)
  • Participants have a sufficient proficiency of the Dutch language

Exclusion criteria

Exclusion Criteria:

  • Participants unable or unwilling to give
  • Participants below 18 years of age
  • Participants not speaking the Dutch language
  • Participants suffering from a pathological condition that may influence energy balance related behaviour (e.g. diabetes,), with significant psychiatric disorder, with history of a bariatric surgery, or with requirements for complex medical diets.
  • Participants who are - because of medical or other specific reasons - not allowed to exercise (e.g. bed-rest).
  • Women having a multiple pregnancy (twin, triplet,...).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
304 participants (actual)
Patient registry
No

Groups and cohorts

  • Data collection

    Data will be collected at four time points over the course of approximately one year and nine months. Participating couples (women and men) will be recruited during the first trimester of their first pregnancy. First measurement will take place in the week of the first routine ultrasound scan (week 12 of pregnancy) (=T0). First follow-up measures will take place six weeks postpartum (=T1). The second and third follow-up measurements will take place at six months postpartum (=T2) and twelve months postpartum (=T3).

    Other: Measurements of body composition

Interventions

  • OtherMeasurements of body composition

    Body weight (SECA digital weighing scale), height (SECA stadiometer), body composition (TANITA Bioelectrical Impedance Analyzer \& skin fold thickness measurements at the biceps, triceps, subscapular and suprailiac sites) and waist circumference (Cescorf measuring tape) will be objectively measured.

06

What researchers measure

Primary outcomes

  1. Change in BMI

    Maternal and paternal body weight and height from which BMI will be calculated

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  2. Change in body composition

    Body composition measured by bio-electrical impedance analysis to estimate fat mass, fat free mass and muscle mass

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  3. Change in body fat

    Skin fold measurements for determing body fat composition by use of a skinfold calliper.

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  4. Changes in dietary intake

    A Food Frequency Questionnaire (FFQ) will be used for assessing dietary intake.

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  5. Change in energy expenditure

    Tri-axial accelerometers (Actigraph) will be used to measure energy expenditure (by ratio of physical activity and sedentary behaviour) objectively over a one-week period.

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  6. Change in physical activity

    Physical activity will be assessed using a self-reported questionnaire (International Physical Activity Questionnaire (IPAQ - Dutch version) and context-specific sedentary behavior.

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  7. Change in sedentary behaviour

    Sedentary behaviour will be assessed using a context-specific sedentary behavior questionnaire.

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

Secondary outcomes

  1. Drop out

    Drop out analysis by using statistical program (SPSS)

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  2. Socio-demographics

    Self-reported questionnaire

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  3. Breastfeeding

    Self-reported questionnaire

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  4. Lifestyle behavior

    Self-reported questionnaire

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  5. Postnatal Depression

    Self-reported 23-item questionnaire

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  6. Partner support

    Self-reported questionnaire for social support from partner about eating and physical activity behaviour

    Time frame: at 12 weeks of pregnancy, at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

  7. New-borns anthropometrics

    Anthropometric measurements to determin new-borns body fat composition

    Time frame: at 6 weeks postpartum, at 6 months postpartum, at 12 months postpartum

07

Study locations

4 sites
  • Ziekenhuis Oost-Limburg
    Genk, Belgium
  • Jessa Ziekenhuis
    Hasselt, Belgium
  • UZ Brussel
    Jette, Belgium
  • UZ Gasthuisberg
    Leuven, Belgium
08

References and documents

Publications

  • Versele V, Bogaerts A, Devlieger R, Matthys C, Gucciardo L, Deliens T, Clarys P, Aerenhouts D. Association between perceived partner support and lifestyle in mother-father dyads expecting a first child. Front Public Health. 2022 Sep 6;10:912768. doi: 10.3389/fpubh.2022.912768. eCollection 2022. PubMed 36148362 ↗
  • Deliens T, Versele V, Vanden Eynde H, Clarys P, Devlieger R, Bogaerts A, Gucciardo L, Schreurs A, Van Holsbeke C, Aerenhouts D. Body weight, body composition and energy balance related behaviour during the transition to parenthood: study protocol of a multi-centre observational follow-up study (TRANSPARENTS). BMC Public Health. 2019 May 6;19(1):516. doi: 10.1186/s12889-019-6884-0. PubMed 31060535 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2018 to primary completion in Jul 2020, 25 months.

Of 52 non-industry observational studies under Health Behavior, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 55. This study's 25 months is close to that.

Counting every sponsor, half of 54 studies reached it within 22 months; a quarter within 4 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2018
First posted
Mar 6, 2018
StartActual
May 25, 2018
Primary completionActual
Jul 13, 2020
CompletionActual
Jul 13, 2020
Last update
Nov 13, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 13, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03454958
Collaborators
KU Leuven
Responsible party
Vicka Versele (PhD student, Vrije Universiteit Brussel) — Principal investigator
First posted
Mar 6, 2018
Start date
May 25, 2018
Primary completion
Jul 13, 2020
Completion
Jul 13, 2020
Last update
Nov 13, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion